IBD remission and stopping methotrexate critical pre-conception: new guidance
Australian-first consensus statements will help clinicians better manage patients with IBD during pregnancy, authors say
Achieving and maintaining remission of inflammatory bowel disease should be prioritised in women before conceiving and during pregnancy, according to new guidance.
Methotrexate, allopurinol and tofacitinib treatment for ulcerative colitis and Crohn’s disease should also be ceased prior to conception to avoid the potential risk of teratogenic effects.
